Glucocorticoids are widely used as potent anti-inflammatory and immunosuppressive drugs to treat a wide range of diseases. However, they are also associated with a number of side effects, including new-onset hyperglycemia in patients without a history of diabetes mellitus (DM) or severely uncontrolled hyperglycemia in patients with known DM. Glucocorticoid-induced diabetes mellitus (GIDM) is a common and potentially harmful problem in clinical practice, affecting almost all medical specialties, but is often difficult to detect in clinical settings. However, scientific evidence is lacking regarding the effects of GIDM, as well as strategies for prevention and treatment. Similarly to nonsteroid-related DM, the principles of early detection and risk factor modification apply. Screening for GIDM should be considered in all patients treated with medium to high doses of glucocorticoids. Challenges in the management of GIDM stem from wide fluctuations in postprandial hyperglycemia and the lack of clearly defined treatment protocols. Together with lifestyle measures, hypoglycemic drugs with insulin-sensitizing effects are indicated. However, insulin therapy is often unavoidable, to the point that insulin can be considered the drug of choice. The treatment of GIDM should take into account the degree and pattern of hyperglycemia, as well as the type, dose, and schedule of glucocorticoid used. Moreover, it is essential to instruct the patient and/or the patient's family about how to perform the necessary adjustments. Prospective studies are needed to answer the remaining questions regarding GIDM.

Citations

Citations to this article as recorded by  

• COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
  Mohsen Pourazizi, Atousa Hakamifard, Alireza Peyman, Rasoul Mohammadi, Shakiba Dehghani, Najmeh Tavousi, Nastaran‐Sadat Hosseini, Hamed Azhdari Tehrani, Bahareh Abtahi‐Naeini
  Parasite Immunology.2024;[Epub]     CrossRef
• Drug-induced hyperglycemia and diabetes
  Marie-Anne Heurtebize, Jean-Luc Faillie
  Therapies.2024; 79(2): 221.     CrossRef
• Immunosuppression in solid organ–transplant recipients and impact on nutrition support
  Nicole K. Wilson, Ann D. Kataria
  Nutrition in Clinical Practice.2024; 39(1): 109.     CrossRef
• The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes
  Vaishali Limbachia, Ian Nunney, Daniel J. Page, Hannah A. Barton, Leena K. Patel, Georgia N. Thomason, Stephan L. Green, Kieran F.J. Lewis, Ketan Dhatariya
  Clinical Therapeutics.2024; 46(2): e59.     CrossRef
• Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study
  Emilie V. Rosager, Amalia Lærke K. Heltø, Cathrine U. Fox Maule, Lennart Friis-Hansen, Janne Petersen, Finn E. Nielsen, Steen B. Haugaard, Rasmus Gregersen
  Diabetes Care.2024; 47(2): 272.     CrossRef
• Cortisol levels across the lifespan in common marmosets (Callithrix jacchus)
  Matthew Lopez, Amaya Seidl, Kimberley A. Phillips
  American Journal of Primatology.2024;[Epub]     CrossRef
• Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
  Maria I. Kaleda, Irina P. Nikishina, Alesya V. Firsa
  Current Pediatrics.2024; 22(6): 546.     CrossRef
• Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
  Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang
  SAGE Open Medicine.2024;[Epub]     CrossRef
• Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
  N. T. Vatutin, E. V. Sklyannaya, V. V. Gribov
  Oncohematology.2024; 19(2): 118.     CrossRef
• The safety and use of perioperative dexamethasone in the perioperative management of primary sporadic supratentorial meningiomas
  Felix Arlt, Alim Emre Basaran, Markus Vogel, Martin Vychopen, Clemens Seidel, Alonso Barrantes-Freer, Erdem Güresir, Johannes Wach
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions
  Liudmila V. Spirina, Vladimir N. Masunov, Denis A. Dyakov, Olga E. Akbasheva, Amina Y. Kebekbayeva, Igor Yu. Shuvalov, Nadezhda V. Masunova, Irina V. Kovaleva, Yumzhana Dagbaeva
  Indian Journal of Clinical Biochemistry.2023; 38(4): 437.     CrossRef
• Mouse Pancreatic Peptide Hormones Probed at the Sub-Single-Islet Level: The Effects of Acute Corticosterone Treatment
  Aleksandra Antevska, Connor C. Long, Samuel D. Dupuy, J. Jason Collier, Michael D. Karlstad, Thanh D. Do
  Journal of Proteome Research.2023; 22(1): 235.     CrossRef
• Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know
  Robert van Wilpe, Abraham H. Hulst, Sarah.E. Siegelaar, J. Hans DeVries, Benedikt Preckel, Jeroen Hermanides
  Journal of Clinical Anesthesia.2023; 84: 111012.     CrossRef
• Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases
  Monika Kleinhans, Lea Jessica Albrecht, Sven Benson, Dagmar Fuhrer, Joachim Dissemond, Susanne Tan
  Journal of Diabetes Science and Technology.2023; : 193229682211479.     CrossRef
• The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis
  Naomi J. Patel, Veronica Tozzo, John M. Higgins, John H. Stone
  Arthritis & Rheumatology.2023; 75(4): 586.     CrossRef
• Characterization, evolution and risk factors of diabetes and prediabetes in a pediatric cohort of renal and liver transplant recipients
  Sophie Welsch, Virginie Mailleux, Priscilla le Hardy de Beaulieu, Nadejda Ranguelov, Nathalie Godefroid, Annie Robert, Xavier Stephenne, Isabelle Scheers, Raymond Reding, Etienne M. Sokal, Philippe A. Lysy
  Frontiers in Pediatrics.2023;[Epub]     CrossRef
• The safety of perioperative dexamethasone with antiemetic dosage in surgical patients with diabetes mellitus: a systematic review and meta-analysis
  Qian-Yun Pang, Jing-Yun Wang, Xiao-Long Liang, Yan Jiang, Hong-Liang Liu
  Perioperative Medicine.2023;[Epub]     CrossRef
• Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
  Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2023; 12(02): 118.     CrossRef
• Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
  Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
  Journal of Clinical Medicine.2023; 12(5): 1906.     CrossRef
• Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats
  Priscila L. Zimath, Milena S. Almeida, Maciel A. Bruxel, Alex Rafacho
  Biochemical Pharmacology.2023; 210: 115486.     CrossRef
• Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia
  L. A. Balykova, V. I. Inchina, T. V. Tarasova, D. A. Khaydar, L. M. Mosina, I. V. Saushev, A. V. Kuchuk, A. Mutvakel, I. V. Begoulov, R. S. Tarasov, P. V. Ageev, D. S. Ovchenkov
  Research and Practical Medicine Journal.2023; 10(1): 90.     CrossRef
• Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
  Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
  International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
• Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
  Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
  Endocrinology and Metabolism.2023; 38(2): 245.     CrossRef
• Zein nanoparticles as oral carrier for mometasone furoate delivery
  Priscila Zimath, Soraia Pinto, Sofia Dias, Alex Rafacho, Bruno Sarmento
  Drug Delivery and Translational Research.2023; 13(11): 2948.     CrossRef
• Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management: A Non-Systematic Literature Review
  Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
  Abdulla Ahmed, Kriss Kania, Hebba Abdul Rahim, Salaheldin Ahmed, Göran Rådegran
  ESC Heart Failure.2023; 10(4): 2427.     CrossRef
• Part II: Interactive case: Drug‐induced endocrine disorders
  Amy C. Donihi
  JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2023; 6(6): 663.     CrossRef
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
  Riccardo Pofi, Giorgio Caratti, David W Ray, Jeremy W Tomlinson
  Endocrine Reviews.2023; 44(6): 975.     CrossRef
• Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
  Yu-Jih Su, Hui-Ming Chen, Tien-Ming Chan, Tien-Tsai Cheng, Shan-Fu Yu, Jia-Feng Chen, Chun-Yu Lin, Chung-Yuan Hsu
  RMD Open.2023; 9(3): e003045.     CrossRef
• The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
  Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S. Tzartos, George P. Paraskevas, Daphne Bakalidou, Georgios Tsivgoulis, Sotirios Giannopoulos
  Journal of Clinical Medicine.2023; 12(15): 4948.     CrossRef
• Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
  Mihaela Simona Popoviciu, Lorena Paduraru, Raluca Marinela Nutas, Alexandra Maria Ujoc, Galal Yahya, Kamel Metwally, Simona Cavalu
  International Journal of Molecular Sciences.2023; 24(16): 12676.     CrossRef
• Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
  Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Manjeshwar Shrinath Baliga, Sucharitha Suresh
  South Asian Journal of Cancer.2023;[Epub]     CrossRef
• The inverse association between DNA gaps and HbA1c levels in type 2 diabetes mellitus
  Jirapan Thongsroy, Apiwat Mutirangura
  Scientific Reports.2023;[Epub]     CrossRef
• Corticosteroids for COVID-19: worth it or not?
  Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
  Molecular Biology Reports.2022; 49(1): 567.     CrossRef
• Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting
  Lauren Longaker, Jennifer N. Clements
  ADCES in Practice.2022; 10(1): 40.     CrossRef
• Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?
  Karine Marchioro Leal, Mariana Barcelos Rocha, Fernanda Venzon Varela, Luana Rodrigues, Priscila Viau Furtado, Fernanda Vieira Amorim da Costa, Álan Gomes Pöppl
  Topics in Companion Animal Medicine.2022; 49: 100648.     CrossRef
• Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
  Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, R. Charlotte Moffett, Nigel Irwin
  Peptides.2022; 152: 170772.     CrossRef
• Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations
  Thiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
  Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
• When therapeutic drugs lead to diabetes
  Bruno Fève, André J. Scheen
  Diabetologia.2022; 65(5): 751.     CrossRef
• Nutrition implications of intrinsic restrictive lung disease
  Sylvia Rinaldi, Christine Balsillie, Cassandra Truchon, Awatif AL‐Mubarak, Marco Mura, Janet Madill
  Nutrition in Clinical Practice.2022; 37(2): 239.     CrossRef
• Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
  Payam Tabarsi, Somayeh Sharifynia, Mihan Pourabdollah Toutkaboni, Zahra Abtahian, Mohammad Rahdar, Arefeh Sadat Mirahmadian, Atousa Hakamifard, Simone Cesaro
  Case Reports in Medicine.2022; 2022: 1.     CrossRef
• Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
  Vasileios Angelis, Stephen R. D. Johnston, Amin Ardestani, Kathrin Maedler
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature
  Victor O. Ukwenya, Sunday A. Adelakun, Temiloluwa A. Fuwape, Ayotunde S. Adeagbo
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
  Rahul Gupta
  Bulletin of the National Research Centre.2022;[Epub]     CrossRef
• Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
  Fei Peng, Xin Li, Fang Xiao, Ruxing Zhao, Zheng Sun
  Trends in Neurosciences.2022; 45(6): 471.     CrossRef
• 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
  Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
  Current Issues in Molecular Biology.2022; 44(5): 2175.     CrossRef
• Management of Glucocorticoid-Induced Hyperglycemia
  Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Sing
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1577.     CrossRef
• Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
  Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Alexandre Barbosa Câmara de Souza, Juliana Pereira, Ana Oliveira Hoff, Marcia Nery
  einstein (São Paulo).2022;[Epub]     CrossRef
• Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
  Rohit Sharma, Praveen Kumar, Abdur Rauf, Ashun Chaudhary, Pradeep Kumar Prajapati, Talha Bin Emran, Clara Mariana Gonçalves Lima, Carlos Adam Conte-Junior
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Black pepper oil (Piper nigrum L.) mitigates dexamethasone induced pancreatic damage via modulation of oxidative and nitrosative stress
  Mona F. Mahmoud, Asmaa M. Elmaghraby, Noura Ali, Islam Mostafa, Assem M. El-Shazly, Mohamed A.O. Abdelfattah, Mansour Sobeh
  Biomedicine & Pharmacotherapy.2022; 153: 113456.     CrossRef
• Various Coated Barrier Membranes for Better Guided Bone Regeneration: A Review
  Ji-Youn Kim, Jun-Beom Park
  Coatings.2022; 12(8): 1059.     CrossRef
• RETROSPECTIVE STUDY ON GLYCAEMIC CONTROL OF THE MIDDLE-AGED PATIENTS RECEIVING STEROID THERAPY IN COVID ICU
  Sayantan Dutta, Sumanta Ghosh Maulik, Jisnu Nayak
  PARIPEX INDIAN JOURNAL OF RESEARCH.2022; : 1.     CrossRef
• Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
  Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström
  Blood Advances.2022; 6(15): 4427.     CrossRef
• Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique
  André J. Scheen, Bruno Fève
  Médecine des Maladies Métaboliques.2022; 16(7): 627.     CrossRef
• Dexamethasone-induced derangement in some liver function parameters: Hepatoprotective effect of L-Citrulline
  Timothy Danboyi, Abdulazeez Jimoh, Evelyn Hassan-Danboyi, AbdulWahab Alhassan, AugustineBanlibo Dubo
  Nigerian Journal of Experimental and Clinical Biosciences.2022; 10(3): 74.     CrossRef
• Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
  Noemí Villén, Albert Roso-Llorach, Carlos Gallego-Moll, Marc Danes-Castells, Sergio Fernández-Bertolin, Amelia Troncoso-Mariño, Monica Monteagudo, Ester Amado, Concepción Violán
  Geriatrics.2022; 7(6): 141.     CrossRef
• Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: A nationwide cohort study in Taiwan
  Yeong-Jang Lin, Chih-Chiang Chien, Chung-Han Ho, Hung-An Chen, Chao-Yu Chen
  Medicine.2022; 101(51): e32520.     CrossRef
• Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
  Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría, Claudia M. Tellez Freitas
  Medicina.2022; 59(1): 56.     CrossRef
• Effect of Ficus lacor Buch. Ham. Fruit Extract on Dexamethasone Induced Insulin Resistant Rats
  V. S. Mule, N. S. Naikwade
  Research Journal of Pharmacy and Technology.2022; : 5559.     CrossRef
• Prednisolone-induced diabetes mellitus in the cat: a historical cohort
  Sivert Nerhagen, Hanne L Moberg, Gudrun S Boge, Barbara Glanemann
  Journal of Feline Medicine and Surgery.2021; 23(2): 175.     CrossRef
• Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
  Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, Julie A. Fischer, Elizabeth M. McNally
  Journal of Neuromuscular Diseases.2021; 8(1): 39.     CrossRef
• A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
  Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
  Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
• Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
  Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos
  Pharmacological Reports.2021; 73(3): 796.     CrossRef
• Epigenetics in blood–brain barrier disruption
  Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin W. McBride, Ari Dienel, Spiros L. Blackburn, Peeyush Kumar Thankamani Pandit
  Fluids and Barriers of the CNS.2021;[Epub]     CrossRef
• Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
  Catherine Li, Patricia Krause, Gretchen Stern
  Endocrine.2021; 73(2): 476.     CrossRef
• Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women
  Wojciech Krzyzanski, Mark A. Milad, Alan H. Jobe, Thomas Peppard, Robert R. Bies, William J. Jusko
  Journal of Pharmacokinetics and Pharmacodynamics.2021; 48(3): 411.     CrossRef
• Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
  Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi, Shruthi Mahalingaiah
  Journal of Exposure Science & Environmental Epidemiology.2021; 31(3): 476.     CrossRef
• New‐onset diabetes in “long COVID”
  Thirunavukkarasu Sathish, Mary Chandrika Anton, Tharsan Sivakumar
  Journal of Diabetes.2021; 13(8): 693.     CrossRef
• Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages
  Yufei Xie, Jiajun Xie, Annemarie H. Meijer, Marcel J. M. Schaaf
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes
  Anthony Aylward, Mei-Lin Okino, Paola Benaglio, Joshua Chiou, Elisha Beebe, Jose Andres Padilla, Sharlene Diep, Kyle J. Gaulton, Michael L. Stitzel
  PLOS Genetics.2021; 17(5): e1009531.     CrossRef
• A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
  Felix Aberer, Daniel A. Hochfellner, Harald Sourij, Julia K. Mader
  Journal of Clinical Medicine.2021; 10(10): 2154.     CrossRef
• Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
  Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Siska Musiam
  Borneo Journal of Pharmacy.2021; 4(2): 84.     CrossRef
• Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
  Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav
  Endocrine and Metabolic Science.2021; 4: 100102.     CrossRef
• Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats
  Younhee Shin, Sathiyamoorthy Subramaniyam, Jin-Mi Chun, Ji-Hyeon Jeon, Ji-Man Hong, Hojin Jung, Boseok Seong, Chul Kim
  Plants.2021; 10(6): 1132.     CrossRef
• Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
  Erika Harno, Charlotte Sefton, Jonathan R. Wray, Tiffany-Jayne Allen, Alison Davies, Anthony P. Coll, Anne White
  Scientific Reports.2021;[Epub]     CrossRef
• Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment
  Filippo Egalini, Mirko Parasiliti Caprino, Giulia Gaggero, Vincenzo Cappiello, Jacopo Giannelli, Ruth Rossetto Giaccherino, Loredana Pagano, Roberta Giordano
  Endocrines.2021; 2(3): 171.     CrossRef
• Current cancer therapies and their influence on glucose control
  Carly Yim, Kerry Mansell, Nassrein Hussein, Terra Arnason
  World Journal of Diabetes.2021; 12(7): 1010.     CrossRef
• Immune‐checkpoint inhibitor‐associated diabetes compared to other diabetes types ‐ A prospective, matched control study
  Sascha R. Tittel, Katharina Laubner, Sebastian M. Schmid, Stefan Kress, Sigrun Merger, Wolfram Karges, Frank J. Wosch, Marcus Altmeier, Marianne Pavel, Reinhard W. Holl
  Journal of Diabetes.2021; 13(12): 1007.     CrossRef
• Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
  Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
  Journal of Fungi.2021; 7(8): 616.     CrossRef
• Antioxidant effects of L-citrulline supplementation in high-fat diet- and dexamethasone-induced Type-2 diabetes mellitus in wistar rats (Rattus norvegicus)
  Evelyn Hassan-Danboyi, Abdulazeez Jimoh, Abdulwahab Alhassan, Timothy Danboyi, KabirAhmed Mohammed, AugustineBanlibo Dubo, Jamilu Haruna, BulusBilly Yakubu
  Nigerian Journal of Experimental and Clinical Biosciences.2021; 9(2): 95.     CrossRef
• ASSESSMENT OF THE POSSIBLE CAUSES OF DIABETES MELLITUS DEVELOPED IN PATIENTS POST COVID-19 TREATMENT IN A TERTIARY CARE HOSPITAL
  KHUJITH RAJUENI, RUTUJA AMBEKAR, HITENDRAPAL SOLANKI, ABDULRAHAMAN ABUBAKAR MOMIN, SUNITA PAWAR
  International Journal of Pharmacy and Pharmaceutical Sciences.2021; : 11.     CrossRef
• Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion
  Brandon J. Kennedy, Ashley M. Lato, Alexander R. Fisch, Susan J. Burke, Justin K. Kirkland, Carson W. Prevatte, Lee E. Dunlap, Russell T. Smith, Konstantinos D. Vogiatzis, J. Jason Collier, Shawn R. Campagna
  ACS Medicinal Chemistry Letters.2021; 12(10): 1568.     CrossRef
• Diabetes in COVID-19 patients: challenges and possible management strategies
  Riyan Al Islam Reshad, Sumaiya Hafiz Riana, Mohammad Al-baruni Chowdhury, Abu Tayab Moin, Faruque Miah, Bishajit Sarkar, Nurnabi Azad Jewel
  The Egyptian Journal of Bronchology.2021;[Epub]     CrossRef
• Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review
  Weronika Gryczyńska, Nikita Litvinov, Bezawit Bitew, Zuzanna Bartosz, Weronika Kośmider, Paweł Bogdański, Damian Skrypnik
  Viruses.2021; 13(12): 2427.     CrossRef
• Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
  Jagriti Upadhyay, Nitin Trivedi, Amos Lal
  Lung.2020; 198(3): 525.     CrossRef
• Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
  Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou
  Toxicology Letters.2020; 320: 19.     CrossRef
• Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
  Mohamad Isam Saeed, Josefin Eklöf, Imane Achir, Pradeesh Sivapalan, Howraman Meteran, Anders Løkke, Tor Biering‐Sørensen, Filip Krag Knop, Jens‐Ulrik Stæhr Jensen
  Diabetes, Obesity and Metabolism.2020; 22(8): 1348.     CrossRef

• Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma

  
  Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman
  International Journal of General Medicine.2020; Volume 13: 131.     CrossRef
• Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers
  Lucy A Ochola, David G Nyamu, Eric M Guantai, Irene W Weru
  Journal of Oncology Pharmacy Practice.2020; 26(4): 823.     CrossRef
• Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with
  Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
  Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume Stoffels, Amanda Lin
  American Journal of Therapeutics.2020; 27(4): e392.     CrossRef
• The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study
  Qingqing Zhao, Jinxin Zhou, Yu Pan, Huijun Ju, Liying Zhu, Yang Liu, Yifan Zhang
  Acta Diabetologica.2020; 57(11): 1383.     CrossRef
• Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
  Jianhua Wu, Sarah L Mackie, Mar Pujades-Rodriguez
  BMJ Open Diabetes Research & Care.2020; 8(1): e001220.     CrossRef
• Diabète et corticoïdes : nouveautés et aspects pratiques
  M. Bastin, F. Andreelli
  La Revue de Médecine Interne.2020; 41(9): 607.     CrossRef
• Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
  Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
  Ebenezer Nyenwe, Deirdre James, Jim Wan, Sam Dagogo-Jack
  Journal of the Endocrine Society.2020;[Epub]     CrossRef
• Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
  Neele Delfs, Tristan Struja, Sandra Gafner, Thaddaeus Muri, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine Angela Blum
  Journal of Clinical Medicine.2020; 9(12): 4079.     CrossRef
• Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
  Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
• Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study
  Imadeldin Elfaki, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr, Salem Abd El-Hadi Habib
  Current Drug Metabolism.2020; 21(14): 1152.     CrossRef
• What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
  Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin, Cengiz Korkmaz
  Clinical Biochemistry.2019; 67: 33.     CrossRef
• Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
  Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki
  International Journal of Endocrinology.2019; 2019: 1.     CrossRef
• Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
  Pragyi Shrestha, Bart van de Sluis, Robin P.F. Dullaart, Jacob van den Born
  Cellular Signalling.2019; 55: 53.     CrossRef
• Understanding the burden of refractory myasthenia gravis
  Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck
  Therapeutic Advances in Neurological Disorders.2019; 12: 175628641983224.     CrossRef
• Drug-induced diabetes type 2: In silico study involving class B GPCRs
  Dorota Latek, Ewelina Rutkowska, Szymon Niewieczerzal, Judyta Cielecka-Piontek, Arun Shukla
  PLOS ONE.2019; 14(1): e0208892.     CrossRef
• Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
  Toshiyuki Takahashi, Takayuki Okamoto, Yasuyuki Sato, Takeshi Yamazaki, Asako Hayashi, Hayato Aoyagi, Michihiko Ueno, Norio Kobayashi, Kimiaki Uetake, Masanori Nakanishi, Tadashi Ariga
  Pediatric Nephrology.2019; 34(1): 87.     CrossRef
• Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
  Milos Tatalovic, Roger Lehmann, Marcus Cheetham, Albina Nowak, Edouard Battegay, Silvana K Rampini
  BMJ Open.2019; 9(5): e028914.     CrossRef
• The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
  Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos Tsonidis
  Clinical Neurology and Neurosurgery.2019; 184: 105450.     CrossRef
• Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life
  Flávia Natividade da Silva, Henver Simionato Brunetta, Maciel Alencar Bruxel, Felipe Azevedo Gomes, Alex Rafacho
  Life Sciences.2019; 237: 116913.     CrossRef
• One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice
  Susan J. Burke, Heidi M. Batdorf, Tai-Yu Huang, Joseph W. Jackson, Katarina A. Jones, Thomas M. Martin, Kristen E. Rohli, Michael D. Karlstad, Tim E. Sparer, David H. Burk, Shawn R. Campagna, Robert C. Noland, Paul L. Soto, J. Jason Collier
  The Journal of Steroid Biochemistry and Molecular Biology.2019; 195: 105468.     CrossRef
• Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
  Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo
  Annals of Intensive Care.2019;[Epub]     CrossRef
• Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
  Amy Hiestand, James Flory, Ritika Chitkara
  Current Diabetes Reports.2019;[Epub]     CrossRef
• Corticothérapie prolongée chez une personne âgée et diabète
  J.L. Schlienger
  Médecine des Maladies Métaboliques.2018; 12(7): 599.     CrossRef
• Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver
  Fatemeh Hassani-Nezhad-Gashti, Jaana Rysä, Outi Kummu, Juha Näpänkangas, Marcin Buler, Mikko Karpale, Janne Hukkanen, Jukka Hakkola
  Biochemical Pharmacology.2018; 148: 253.     CrossRef
• Diabetes Mellitus Secondary to Cushing’s Disease
  Mattia Barbot, Filippo Ceccato, Carla Scaroni
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
  Anjana Radhakutty, Morton G Burt
  European Journal of Endocrinology.2018; 179(4): R207.     CrossRef
• Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study
  Ala Keyany, Johannes T.H. Nielen, Patrick C. Souverein, Frank de Vries, Bart van den Bemt
  Diabetes Research and Clinical Practice.2018; 139: 100.     CrossRef
• Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
  Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
  Scientific Reports.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes
  Karlijn A. C. Meeks, Amy R. Bentley, Themistocles L. Assimes, Nora Franceschini, Adebowale A. Adeyemo, Charles N. Rotimi, Ayo P. Doumatey
  Genome Medicine.2023;[Epub]     CrossRef
• Glucose- and Bile Acid-Stimulated Secretion of Gut Hormones in the Isolated Perfused Intestine Is Not Impaired in Diet-Induced Obese Mice
  Jenna E. Hunt, Jens J. Holst, Sara L. Jepsen
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
  Fei Yang, Shan Dang, Hongjun LV, Bingyin Shi
  Journal of International Medical Research.2021; 49(1): 030006052098566.     CrossRef
• Elevated levels of fasting serum GIP may be protective factors for diabetic retinopathy in type 2 diabetes mellitus
  LingHong Huang, JingXiong Zhou, Bo Liang, HuiBin Huang, LiangYi Li
  International Journal of Diabetes in Developing Countries.2021; 41(4): 543.     CrossRef
• Enteroendocrine K and L cells in healthy and type 2 diabetic individuals
  Tina Jorsal, Nicolai A. Rhee, Jens Pedersen, Camilla D. Wahlgren, Brynjulf Mortensen, Sara L. Jepsen, Jacob Jelsing, Louise S. Dalbøge, Peter Vilmann, Hazem Hassan, Jakob W. Hendel, Steen S. Poulsen, Jens J. Holst, Tina Vilsbøll, Filip K. Knop
  Diabetologia.2018; 61(2): 284.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef

Citations

Citations to this article as recorded by  

• Cardiovascular age of workers with different employment categories
  Byung-Kook Lee, Jaeouk Ahn, Nam-Soo Kim, Jungsun Park, Yangho Kim
  Archives of Environmental & Occupational Health.2022; 77(3): 243.     CrossRef
• Effects of Anthocyanin-rich Berries on the Risk of Metabolic Syndrome: A Systematic Review and Meta-analysis
  Mikkel Roulund Wilken, Max Norman Tandrup Lambert, Christine Bodelund Christensen, Per Bendix Jeppesen
  Review of Diabetic Studies.2022; 18(1): 42.     CrossRef
• Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study
  Jihong Hu, Brian Thompson, Shuxia Wang, Minhao Guo, Chunjuan Yan, Fengfeng Ding, Peng Guo, Li Chen, Zhuoma Cao, Jianzong Wang
  Medicine.2022; 101(43): e31320.     CrossRef
• Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study
  Azra Ramezankhani, Fereidoun Azizi, Farzad Hadaegh
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• The Association of Metabolic Syndrome with the development of cardiovascular disease among Kazakhs in remote rural areas of Xinjiang, China: a cohort study
  Wenwen Yang, Shuxia Guo, Haixia Wang, Yu Li, Xianghui Zhang, Yunhua Hu, Heng Guo, Kui Wang, Yizhong Yan, Jingyu Zhang, Jiaolong Ma, Lei Mao, Lati Mu, Jiaming Liu, Yanpeng Song, Changjing Li, Zhuo Ma, Rulin Ma, Jia He
  BMC Public Health.2021;[Epub]     CrossRef
• Serum Arylsulfatase and Acid Phosphatase Activity in Patients with Metabolic Syndrome as a Result of Oxidative Damage to Lysosomes
  Dorota M. Olszewska-Słonina
  Protein & Peptide Letters.2021; 28(11): 1246.     CrossRef
• Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
  Jae Hyun Bae, Min Kyong Moon, Sohee Oh, Bo Kyung Koo, Nam Han Cho, Moon-Kyu Lee
  Diabetes & Metabolism Journal.2020; 44(3): 458.     CrossRef
• The Prevalence of Obesity and Metabolic Syndrome in the Korean Military Compared with the General Population
  Jung Hwan Lee, Da Hea Seo, Min Jung Nam, Geon Hui Lee, Dong Hee Yang, Min Joo Lee, Ung-Rim Choi, Seongbin Hong
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• Relationship between serum bilirubin levels and cardiovascular disease
  Sunghwan Suh, Young Rak Cho, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee, Christian Herder
  PLOS ONE.2018; 13(2): e0193041.     CrossRef
• Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang
  Wenwen Yang, Rulin Ma, Xianghui Zhang, Heng Guo, Jia He, Lei Mao, Lati Mu, Yunhua Hu, Yizhong Yan, Jiaming Liu, Jiaolong Ma, Shugang Li, Yusong Ding, Mei Zhang, Jingyu Zhang, Shuxia Guo
  Scientific Reports.2018;[Epub]     CrossRef
• Impact of interactions among metabolic syndrome components on the development of cardiovascular disease among Kazakhs in Xinjiang
  Wenwen Yang, Xiang Gao, Xianghui Zhang, Yunhua Hu, Heng Guo, Kui Wang, Yizhong Yan, Jia He, Jingyu Zhang, Jiaolong Ma, Lei Mao, Lati Mu, Jiaming Liu, Shugang Li, Yusong Ding, Mei Zhang, Rulin Ma, Shuxia Guo, Mahesh Narayan
  PLOS ONE.2018; 13(10): e0205703.     CrossRef
• Prediction of cardiovascular disease in Korean population: based on health risk appraisal of national health screening program
  Jae Moon Yun, Tae Gon Yoo, Seung-Won Oh, Be Long Cho, Eunyoung Kim, Insob Hwang
  Journal of the Korean Medical Association.2017; 60(9): 746.     CrossRef
• Metabolic Syndrome Is a Strong Risk Factor for Minor Ischemic Stroke and Subsequent Vascular Events
  Guang-Sheng Wang, Dao-Ming Tong, Xiao-Dong Chen, Tong-Hui Yang, Ye-Ting Zhou, Xiao-Bo Ma, Gianpaolo Reboldi
  PLOS ONE.2016; 11(8): e0156243.     CrossRef
• Metabolic syndrome related to cardiovascular events in a 10-year prospective study
  Laura Kazlauskienė, Jūratė Butnorienė, Antanas Norkus
  Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
• Articles in 'Endocrinology and Metabolism' in 2014
  Won-Young Lee
  Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
• Impact of Cadmium Exposure on the Association between Lipopolysaccharide and Metabolic Syndrome
  Seung Han, Kyoung Ha, Ja Jeon, Hae Kim, Kwan Lee, Dae Kim
  International Journal of Environmental Research and Public Health.2015; 12(9): 11396.     CrossRef
• Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression
  Wei-Jen Ting, Wei-Wen Kuo, Dennis Hsieh, Yu-Lan Yeh, Cecilia-Hsuan Day, Ya-Hui Chen, Ray-Jade Chen, Viswanadha Padma, Yi-Hsing Chen, Chih-Yang Huang
  International Journal of Molecular Sciences.2015; 16(10): 25881.     CrossRef

Citations

Citations to this article as recorded by  

• Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis
  Bong Soo Cha, Jae Hyuk Lee
  Journal of Korean Endocrine Society.2007; 22(3): 188.     CrossRef